Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Kura Oncology to Participate in Bank of America Securities Healthcare Conference
-
InflaRx Reports First Quarter 2024 Financial Results and Provides Business Update
-
BioRestorative Therapies Enhances Preclinical Metabolic Program with a Novel Exosome-Based Biologic Targeting Obesity
-
Genie Energy Announces First Quarter 2024 Results
-
FitLife Brands Announces First Quarter Earnings Call and its Participation at Sidoti Virtual Investor Conference and Provides Operational Update
-
Nexxen to Announce First Quarter 2024 Financial Results on May 20, 2024
-
Kelly to Participate in the 18th Annual Barrington Research Virtual Spring Investment Conference
-
Else Nutrition Expands Product Listings at Major U.S. Food Retailer
-
Amerigo Announces Q1-2024 Results & Quarterly Dividend
-
Verrica Pharmaceuticals to Provide a Corporate Update and Report First Quarter 2024 Financial Results on May 13, 2024
-
WEMADE and WEMIX Win “Best Web3 Gaming” at MENA Games Industry Awards 2024
-
Ladybug Signs LOI to Purchase Ecommerce Site from Your Supplement Supply Store Ltd.
-
Alterity Therapeutics Phase 2 Data Monitoring Committee Recommends Continuing Clinical Trial as Planned After Third Review
-
Form 8.5 (EPT/RI) - Centaur Media plc
-
Atlantica Reports First Quarter 2024 Financial Results
-
WTW boosts global cyber facility with increased capacity and broader coverage options
-
Vishay Intertechnology Reports First Quarter 2024 Results
-
SchooLinks Recognized Among America's Best Startup Employers by Forbes and Inc.
-
SchooLinks Recognized Among America's Best Startup Employers by Forbes and Inc.
-
Wolters Kluwer 2024 Annual General Meeting of Shareholders adopts all resolutions
-
Gilat Reports First Quarter 2024 Results
-
Celcuity Inc. Schedules Release of First Quarter 2024 Financial Results and Webcast/Conference Call
-
Vertex Announces First Quarter 2024 Financial Results
-
Olema Oncology Announces New Clinical Data for Palazestrant in Combination with Ribociclib to be Presented at the 2024 ESMO Breast Cancer Annual Congress
-
MegaWatt Metals Provides Corporate Update, Including Advancing Clean-Energy Focus Through Agreement to Acquire Uranium Property
-
Black Diamond Group Limited Announces Renewal of Normal Course Issuer Bid
-
Brink's Announces Strong First-Quarter Results and Affirms Full Year Guidance
-
Sprott Announces First Quarter 2024 Results
-
StateHouse Announces Receipt of Failure to File Cease Trade Order
-
Brink's Announces Strong First-Quarter Results and Affirms Full Year Guidance
-
CanLift Celebrates 15 Years of Business in Ontario
-
SpringWorks Therapeutics to Participate in the BofA Securities 2024 Health Care Conference
-
Aura Biosciences to Participate in Upcoming Investor Conferences
-
Kamada Reports Strong First Quarter 2024 Financial Results with Year-Over-Year Top-Line Growth of 23% and a 96% Increase in Profitability; Raises Full-Year Financial Guidance
-
Cingulate Reports First Quarter 2024 Financial Results and Provides Clinical and Business Update
-
Brunswick Exploration Drills 93.45 Meters at 1.55% Li2O at MR-6
-
Standard Uranium Begins Inaugural Drill Program at Canary Project, Eastern Athabasca Basin
-
Microbix Schedules Release of Results for Q2 Fiscal 2024
-
Hain Celestial Reports Fiscal Third Quarter 2024 Financial Results
-
Amicus Therapeutics to Present at the Bank of America 2024 Health Care Conference
-
Bio-Path Holdings to Announce First Quarter 2024 Financial Results on May 15, 2024
-
R1 RCM Reports First Quarter 2024 Results
-
EyePoint Pharmaceuticals Reports First Quarter 2024 Financial Results and Highlights Recent Corporate Developments
-
Dragonfly Energy Named Business of the Year at Nevada Business Awards
-
Cartesian Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Update
-
Sage launches two new integrated suites in Canada and the UK to help Accountants and Small Businesses drive growth
-
Avadel Pharmaceuticals Provides Corporate Update and Reports First Quarter 2024 Financial Results
-
Arbor Biotechnologies Announces Acquisition of Serendipity
-
Beasley Broadcast Group Reports First Quarter Revenue of $54.4 Million
-
PolyPid Provides Corporate Update and Reports First Quarter 2024 Financial Results
